ClinicalTrials.govpublic full text
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)
non-small cell lung cancer, non-small cell lung carcinoma;, stage iii;, unresectable;, vaccine; tecemotide; l-blp25;, cyclophosphamide;, placebo controlled;, randomized;, double blind;, immunotherapy;, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874974
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.